Continuous glucose monitoring in IC

Not Applicable

Recruiting

• Conditions: blood glucose control in critically ill patients; Metabolic and Endocrine - Metabolic disorders; Blood - Other blood disorders

• Registration Number: ACTRN12612000130864
• Lead Sponsor: niversity of Canterbury

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-01-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

(i) The participant is treated using intensive insulin therapy, (ii) Expected to remain in ICU for at least 3-5 days, and (iii) a platelet count > 30,000 per micro-litre

Exclusion Criteria

(i) Not expected to survive intensive care, (ii) Unable to obtain consent, (iii) Any conditions that might preclude the use of CGM such as skin lesions affecting proposed insertion areas, (iv)Lack of clinical equipoise, (v) Pregnant subjects, and (vi) subject is receiving treatment that includes Hydroxyurea.

Study & Design

• Study Type: Observational
• Study Design: Not specified